Strongbridge Bio Ord (SBBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | SBBP | CRDF | CGEN | ||
Company | Strongbridge Bio Ord | Cardiff Oncology Inc | Compugen Ltd | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 1.96 | 2.67 | 1.5100 | ||
High | 2.06 | 2.68 | 1.5400 | ||
Low | 1.95 | 2.56 | 1.4900 | ||
Last | 2.00 | 2.58 | 1.4950 | ||
Change | +0.03 | -0.08 | -0.0050 | ||
% Change | +1.52% | -3.01% | -0.33% | ||
Volume | 684,600 | 237,261 | 58,637 | ||
20-Day Average Volume | 234,660 | 899,223 | 369,508 | ||
Previous Close | 1.97 | 2.66 | 1.5000 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 2.10 | 2.88 | 1.5541 | ||
20-Day Raw Stochastic | 13.51% | 11.97% | 32.46% | ||
20-Day Relative Strength | 42.28% | 46.33% | 44.45% | ||
Weighted Alpha | -28.48 | -3.04 | -16.40 | ||
Today's Opinion | 100% Sell | 24% Sell | 100% Sell | ||
Previous Opinion | 100% Sell | 24% Sell | 100% Sell | ||
Last Month's Opinion | 88% Sell | 40% Buy | 72% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -2.91% since 09/28/21 | +6.73% since 11/25/24 | +7.24% since 11/25/24 | ||
Low | 1.95 on 10/05/21 | 2.38 on 11/26/24 | 1.3700 on 11/26/24 | ||
High | 2.11 on 09/29/21 | 2.69 on 12/02/24 | 1.6700 on 11/27/24 | ||
1-Month | |||||
%Chg | -10.71% since 09/03/21 | -18.41% since 11/01/24 | -11.57% since 11/01/24 | ||
Low | 1.95 on 10/05/21 | 2.38 on 11/26/24 | 1.3500 on 11/15/24 | ||
High | 2.32 on 09/10/21 | 4.38 on 11/07/24 | 1.8494 on 11/07/24 | ||
3-Month | |||||
%Chg | -35.06% since 07/02/21 | +19.41% since 09/03/24 | -21.24% since 09/03/24 | ||
Low | 1.85 on 08/16/21 | 2.09 on 09/06/24 | 1.3500 on 11/15/24 | ||
High | 3.19 on 07/06/21 | 4.38 on 11/07/24 | 2.0100 on 09/12/24 | ||
6-Month | |||||
%Chg | -28.06% since 04/05/21 | -17.51% since 06/03/24 | -30.95% since 06/03/24 | ||
Low | 1.85 on 08/16/21 | 2.01 on 08/05/24 | 1.3500 on 11/15/24 | ||
High | 3.19 on 07/06/21 | 4.38 on 11/07/24 | 2.2100 on 06/06/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 135,658 | 136,016 | 133,855 | ||
Shares Outstanding, K | 67,829 | 51,134 | 89,237 | ||
Annual Sales | 30,730,000 | 490,000 | 33,460,000 | ||
Annual Net Income | -45,080,000 | -41,440,000 | -18,750,000 | ||
Last Quarter Sales | 10,040,000 | 170,000 | 17,130,000 | ||
Last Quarter Net Income | -13,240,000 | -11,860,000 | 1,280,000 | ||
60-Month Beta | 1.59 | 1.89 | 2.59 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A on 08/05/21 | -0.25 on 11/07/24 | 0.01 on 11/12/24 | ||
Latest Earnings Date | 11/04/21 | 11/07/24 | 11/12/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 79.50 |